United States

Portage Biotech Inc.

Track

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Allan L. Shaw Affiliate
Transaction date
Proposed sale
Price
26.70
Quantity 66,171
Value US$4,087,388
3.3
Allan L. Shaw Affiliate
Transaction date
Proposed sale
Price
304.11
Quantity 40,159
Value US$2,683,436
Steven Mintz Director Non-Executive Director
Transaction date
Proposed sale
Price
369.55
Quantity 85,218
Value US$3,259,143
Steven Mintz Director Non-Executive Director
Transaction date
Proposed sale
Price
15.96
Quantity 6,545
Value US$104,457
3.7
Gregory Bailey Director Non-Executive Director
Transaction date
Proposed sale
Price
17.65
Quantity 70,000
Value US$1,235,719
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-03 2024-10-03 PrS Proposed sale
3.3
Allan L. Shaw

Affiliate
66,171
26.70
US$4,087,388 		66,171 26.70 US$4,087,388
2024-09-27 2024-09-27 PrS Proposed sale
3.3
Allan L. Shaw

Affiliate
40,159
304.11
US$2,683,436 		40,159 304.11 US$2,683,436
2024-09-23 2024-09-18 PrS Proposed sale
Steven Mintz

Director

Non-Executive Director
85,218
369.55
US$3,259,143 		85,218 369.55 US$3,259,143
2024-09-23 2024-09-18 PrS Proposed sale
Steven Mintz

Director

Non-Executive Director
6,545
15.96
US$104,457 		6,545 15.96 US$104,457
2024-09-20 2024-09-18 PrS Proposed sale
3.7
Gregory Bailey

Director

Non-Executive Director
70,000
17.65
US$1,235,719 		70,000 17.65 US$1,235,719
Explore more

More insider trading research around Portage Biotech Inc.

More insider trades in United States
Insider trading in North America